NASDAQ : NAGE
Niagen Bioscience, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.5 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 198.23M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Niagen Bioscience, Inc. (NAGE) reported revenue of 129.08M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 129.08M | 129.42M | 99.60M | 83.57M | 72.05M | 67.45M |
| Cost of Revenue | 46.16M | 46.23M | 38.01M | 32.79M | 29.25M | 25.96M |
| Gross Profit | 82.92M | 83.19M | 61.59M | 50.78M | 42.80M | 41.49M |
| Selling, General & Admin | 67.81M | 62.56M | 47.84M | 51.42M | 56.60M | 64.73M |
| Research & Development | 6.50M | 6.33M | 6.02M | 4.96M | 4.83M | 3.83M |
| Operating Expenses | 74.31M | 68.89M | 53.86M | 56.38M | 61.42M | 68.56M |
| Operating Income | 8.62M | 14.30M | 7.73M | -5.60M | -18.63M | -27.07M |
| Interest Expense | -55.00K | |||||
| Interest & Investment Income | 1.86M | 2.13M | 1.13M | 661.00K | 3.00K | |
| Other Non Operating Income (Expenses) | -214.00K | -214.00K | ||||
| EBT Excluding Unusual Items | 10.26M | 16.21M | 8.86M | -4.94M | -18.62M | -27.13M |
| Other Unusual Items | 1.98M | 1.98M | 2.08M | |||
| Pretax Income | 17.03M | 18.19M | 8.86M | -4.94M | -16.54M | -27.13M |
| Income Tax Expense | 1.04M | 810.00K | 305.00K | |||
| Earnings From Continuing Operations | 15.99M | 17.38M | 8.55M | -4.94M | -16.54M | -27.13M |
| Net Income | 15.99M | 17.38M | 8.55M | -4.94M | -16.54M | -27.13M |
| Net Income to Common | 15.99M | 17.38M | 8.55M | -4.94M | -16.54M | -27.13M |
| Shares Outstanding (Basic) | 79.72M | 79.18M | 75.93M | 74.98M | 69.73M | 67.19M |
| Shares Outstanding (Diluted) | 84.73M | 85.44M | 78.12M | 74.98M | 69.73M | 67.19M |
| EPS (Basic) | 0.20 | 0.22 | 0.11 | -0.07 | -0.24 | -0.40 |
| EPS (Diluted) | 0.19 | 0.20 | 0.11 | -0.07 | -0.24 | -0.40 |
| Free Cash Flow | 5.67M | 13.21M | 11.95M | 6.97M | -15.43M | -24.57M |
| Free Cash Flow Per Share | 0.07 | 0.15 | 0.15 | 0.09 | -0.22 | -0.37 |
| Gross Margin | 64.24% | 64.28% | 61.83% | 60.76% | 59.40% | 61.51% |
| Operating Margin | 6.67% | 11.05% | 7.76% | -6.70% | -25.85% | -40.14% |
| Profit Margin | 12.39% | 13.43% | 8.58% | -5.91% | -22.96% | -40.22% |
| Free Cash Flow Margin | 4.40% | 10.21% | 11.99% | 8.34% | -21.42% | -36.43% |
| EBITDA | 9.59M | 15.08M | 8.54M | -4.57M | -17.57M | -25.96M |
| EBITDA Margin | 7.43% | 11.65% | 8.58% | -5.47% | -24.39% | -38.48% |
| D&A For EBITDA | 976.00K | 785.00K | 814.00K | 1.03M | 1.05M | 1.11M |
| EBIT | 8.62M | 14.30M | 7.73M | -5.60M | -18.63M | -27.07M |
| EBIT Margin | 6.67% | 11.05% | 7.76% | -6.70% | -25.85% | -40.14% |
| Effective Tax Rate | 6.09% | 4.45% | 3.44% | |||
| Advertising Expenses | 12.65M | 11.10M | 10.30M | 11.40M | 12.50M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 66.59M | 64.64M | 44.51M | 27.17M | 20.29M | 28.02M |
| Cash & Short-Term Investments | 66.59M | 64.64M | 44.51M | 27.17M | 20.29M | 28.02M |
| Receivables | 8.58M | 9.74M | 7.77M | 5.23M | 8.48M | 5.23M |
| Inventory | 20.64M | 20.42M | 9.19M | 14.53M | 14.68M | 13.60M |
| Prepaid Expenses | 1.83M | 1.31M | 2.48M | 2.45M | 2.97M | 1.86M |
| Restricted Cash | 152.00K | 152.00K | 152.00K | 152.00K | 152.00K | 200.00K |
| Other Current Assets | 541.00K | |||||
| Total Current Assets | 97.79M | 96.81M | 64.10M | 49.53M | 46.57M | 48.91M |
| Property, Plant & Equipment | 3.09M | 3.52M | 3.45M | 4.54M | 6.32M | 7.36M |
| Other Intangible Assets | 5.31M | 5.66M | 359.00K | 510.00K | 671.00K | 857.00K |
| Other Long-Term Assets | 405.00K | 425.00K | 368.00K | 383.00K | 497.00K | 723.00K |
| Total Assets | 106.59M | 106.41M | 68.28M | 54.96M | 54.06M | 57.84M |
| Accounts Payable | 9.44M | 10.80M | 8.53M | 10.23M | 9.68M | 10.42M |
| Accrued Expenses | 3.84M | 7.72M | 7.82M | 9.49M | 7.34M | 6.48M |
| Current Portion of Leases | 917.00K | 1.00M | 994.00K | 702.00K | 696.00K | 548.00K |
| Current Unearned Revenue | 329.00K | 399.00K | 611.00K | 195.00K | 157.00K | 161.00K |
| Other Current Liabilities | 524.00K | |||||
| Total Current Liabilities | 15.05M | 19.92M | 17.95M | 20.62M | 17.87M | 17.61M |
| Long-Term Leases | 1.41M | 1.81M | 1.66M | 2.58M | 3.56M | 4.15M |
| Long-Term Unearned Revenue | 2.43M | 2.67M | 2.58M | 3.31M | 3.96M | 4.35M |
| Other Long-Term Liabilities | 5.17M | 5.46M | ||||
| Total Liabilities | 24.06M | 29.87M | 22.18M | 26.51M | 25.39M | 26.11M |
| Common Stock | 79.00K | 79.00K | 77.00K | 75.00K | 74.00K | 68.00K |
| Additional Paid-In Capital | 239.70M | 240.99M | 227.93M | 218.84M | 214.09M | 200.61M |
| Retained Earnings | -157.25M | -164.53M | -181.91M | -190.46M | -185.49M | -168.95M |
| Comprehensive Income & Other | -2.00K | -9.00K | -4.00K | -4.00K | -3.00K | -2.00K |
| Shareholders' Equity | 82.53M | 76.53M | 46.09M | 28.46M | 28.67M | 31.73M |
| Total Liabilities & Equity | 106.59M | 106.41M | 68.28M | 54.96M | 54.06M | 57.84M |
| Total Debt | 2.33M | 2.82M | 2.65M | 3.28M | 4.26M | 4.70M |
| Net Cash (Debt) | 64.26M | 61.82M | 41.86M | 23.90M | 16.03M | 23.32M |
| Net Cash Per Share | 0.76 | 0.72 | 0.54 | 0.32 | 0.23 | 0.35 |
| Filing Date Shares Outstanding | 79.29M | 80.25M | 77.92M | 75.48M | 75.02M | 68.49M |
| Total Common Shares Outstanding | 79.08M | 79.88M | 77.50M | 75.15M | 74.75M | 68.31M |
| Working Capital | 82.74M | 76.89M | 46.15M | 28.91M | 28.70M | 31.29M |
| Book Value Per Share | 1.04 | 0.96 | 0.59 | 0.38 | 0.38 | 0.46 |
| Tangible Book Value | 77.22M | 70.87M | 45.73M | 27.95M | 28.00M | 30.87M |
| Tangible Book Value Per Share | 0.98 | 0.89 | 0.59 | 0.37 | 0.37 | 0.45 |
| Machinery | 3.54M | 3.97M | 4.26M | 4.05M | 4.30M | |
| Construction In Progress | 45.00K | 86.00K | 5.00K | 172.00K | 91.00K | |
| Leasehold Improvements | 2.21M | 2.21M | 2.15M | 2.06M | 2.39M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 15.99M | 17.38M | 8.55M | -4.94M | -16.54M | -27.13M |
| Depreciation & Amortization | 1.66M | 1.45M | 1.48M | 1.71M | 1.88M | 1.63M |
| Loss (Gain) From Sale of Assets | -4.76M | 4.00K | -19.00K | -5.00K | 7.00K | |
| Asset Writedown & Restructuring Costs | 3.00K | |||||
| Stock-Based Compensation | 6.94M | 6.07M | 3.66M | 4.75M | 5.74M | 6.20M |
| Provision & Write-off of Bad Debts | 34.00K | -1.22M | -1.25M | 964.00K | 63.00K | 46.00K |
| Other Operating Activities | -1.66M | -1.89M | -3.44M | 75.00K | 67.00K | 108.00K |
| Change in Accounts Receivable | 1.04M | -756.00K | -1.28M | 2.25M | -3.32M | -2.58M |
| Change in Inventory | -6.62M | -11.63M | 5.33M | 152.00K | -1.08M | -1.92M |
| Change in Accounts Payable | -4.24M | 2.27M | -1.07M | 553.00K | -744.00K | 978.00K |
| Change in Unearned Revenue | -212.00K | -122.00K | -316.00K | -606.00K | -396.00K | -211.00K |
| Change in Other Net Operating Assets | -2.23M | 1.95M | 463.00K | 2.21M | -783.00K | -1.28M |
| Operating Cash Flow | 5.95M | 13.50M | 12.11M | 7.12M | -15.10M | -24.16M |
| Capital Expenditures | -275.00K | -292.00K | -163.00K | -148.00K | -334.00K | -409.00K |
| Sale of Property, Plant & Equipment | 20.00K | 5.00K | ||||
| Other Investing Activities | -497.00K | |||||
| Investing Cash Flow | 5.03M | -292.00K | -143.00K | -143.00K | -334.00K | -409.00K |
| Long-Term Debt Repaid | -12.00K | -11.00K | -15.00K | -16.00K | -31.00K | |
| Net Debt Issued (Repaid) | -6.00K | -12.00K | -11.00K | -15.00K | -16.00K | -31.00K |
| Issuance of Common Stock | 769.00K | 7.25M | 5.43M | 7.75M | 36.23M | |
| Repurchase of Common Stock | -5.37M | -251.00K | ||||
| Other Financing Activities | -102.00K | -67.00K | -52.00K | -75.00K | -77.00K | -110.00K |
| Financing Cash Flow | -4.71M | 6.92M | 5.37M | -90.00K | 7.65M | 36.09M |
| Net Cash Flow | 6.27M | 20.13M | 17.34M | 6.88M | -7.78M | 11.52M |
| Free Cash Flow | 5.67M | 13.21M | 11.95M | 6.97M | -15.43M | -24.57M |
| Free Cash Flow Margin | 4.40% | 10.21% | 11.99% | 8.34% | -21.42% | -36.43% |
| Free Cash Flow Per Share | 0.07 | 0.15 | 0.15 | 0.09 | -0.22 | -0.37 |
| Levered Free Cash Flow | 1.64M | 5.55M | 9.61M | 9.47M | -9.64M | -13.50M |
| Unlevered Free Cash Flow | 1.64M | 5.55M | 9.61M | 9.47M | -9.64M | -13.46M |
| Cash Interest Paid | 1.00K | 1.00K | 1.00K | 2.00K | 1.00K | 1.00K |
| Change in Working Capital | -12.26M | -8.30M | 3.13M | 4.56M | -6.32M | -5.01M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 189.11M | 508.63M | 406.10M | 107.67M | 125.41M | 255.75M |
| Enterprise Value | 124.85M | 447.55M | 376.75M | 84.83M | 116.73M | 226.20M |
| Last Close Price | 2.33 | 6.36 | 5.30 | 1.43 | 1.68 | 3.74 |
| PE Ratio | 12.54 | 29.26 | 47.50 | |||
| Forward PE | 40.85 | 27.81 | 50.28 | 160.00 | 160.00 | 160.00 |
| PS Ratio | 1.43 | 3.93 | 4.08 | 1.29 | 1.74 | 3.79 |
| PB Ratio | 2.23 | 6.65 | 8.81 | 3.78 | 4.37 | 8.06 |
| P/TBV Ratio | 2.39 | 7.18 | 8.88 | 3.85 | 4.48 | 8.29 |
| P/FCF Ratio | 32.56 | 38.50 | 33.99 | 15.45 | ||
| P/OCF Ratio | 31.06 | 37.66 | 33.54 | 15.13 | ||
| EV/Sales Ratio | 0.93 | 3.46 | 3.78 | 1.01 | 1.62 | 3.35 |
| EV/EBITDA Ratio | 12.56 | 29.68 | 44.12 | |||
| EV/EBIT Ratio | 13.99 | 31.31 | 48.76 | |||
| EV/FCF Ratio | 21.24 | 33.87 | 31.54 | 12.17 | ||
| Debt / Equity Ratio | 0.03 | 0.04 | 0.06 | 0.12 | 0.15 | 0.15 |
| Debt / EBITDA Ratio | 0.21 | 0.17 | 0.27 | |||
| Debt / FCF Ratio | 0.41 | 0.21 | 0.22 | 0.47 | ||
| Net Debt / Equity Ratio | -0.78 | -0.81 | -0.91 | -0.84 | -0.56 | -0.73 |
| Net Debt / EBITDA Ratio | -6.70 | -4.10 | -4.90 | 5.23 | 0.91 | 0.90 |
| Net Debt / FCF Ratio | -11.32 | -4.68 | -3.50 | -3.43 | 1.04 | 0.95 |
| Asset Turnover | 1.30 | 1.48 | 1.62 | 1.53 | 1.29 | 1.40 |
| Inventory Turnover | 2.63 | 3.12 | 3.21 | 2.25 | 2.07 | 2.05 |
| Quick Ratio | 5.00 | 3.73 | 2.91 | 1.57 | 1.61 | 1.89 |
| Current Ratio | 6.50 | 4.86 | 3.57 | 2.40 | 2.61 | 2.78 |
| Return on Equity (ROE) | 21.80% | 28.35% | 22.94% | -17.29% | -54.77% | -112.68% |
| Return on Assets (ROA) | 5.44% | 10.23% | 7.84% | -6.42% | -20.81% | -35.18% |
| Return on Invested Capital (ROIC) | 44.00% | 144.16% | 169.60% | -65.11% | -176.99% | -542.87% |
| Return on Capital Employed (ROCE) | 9.40% | 16.50% | 15.40% | -16.30% | -51.50% | -67.30% |
| Earnings Yield | 7.97% | 3.42% | 2.10% | -4.59% | -13.19% | -10.61% |
| FCF Yield | 3.07% | 2.60% | 2.94% | 6.47% | -12.31% | -9.61% |
| Buyback Yield / Dilution | -2.25% | -9.36% | -4.19% | -7.54% | -3.79% | -10.02% |